DoP may exempt 11 more drugs from public procurement rules
New Delhi: The Department of Pharmaceuticals (DoP) has proposed to add 11 more drugs including insulin and monoclonal antibodies to the list of 84 drug formulations it has mentioned in…
Centre plans separate licence regime for bulk drugs, APIs: Report
India is preparing to revamp its pharmaceutical licensing system amid growing scrutiny over drug safety lapses. Mint has learnt that the government is working on a separate wholesale licensing framework…
DoP includes member of HTAIn in expert committee on pricing of drugs
New Delhi: Department of Pharmaceuticals (DoP) has added an expert representative from the Health Technology Assessment of India (HTAIn) under the Department of Health Research (DHR) as a member of…
Bulk drug imports from China slow
There is still some way until India’s dependence on imports of active pharmaceutical ingredients (APIs) and intermediates from China reduces, but the growth rate of imports has come down. While…
US FDA Warns Two Drugmakers Including Medgel From India Over DEG, EG Testing Lapses
Maryland : The US Food and Drug Administration (FDA) has reprimanded two drugmakers — Avlon Industries based in Melrose Park, Illinois, and Medgel based in Pithampur, Madhya Pradesh, India — over…
DCGI Asks Manufacturers Not To Submit Same Batch Of Cough Syrup To More Than One Lab
New Delhi : The Drugs Controller General of India (DCGI) has directed the manufacturers not to submit the same batch of cough syrup to more than one laboratory at a time,…
Top Drugmakers Bet On Trade Generics To Grow Beyond Metros
Mumbai : Trade generics is seeing a lot of action in recent times with the entry of large domestic pharmaceutical companies, who want to expand beyond metros and other top…










